Cite
HARVARD Citation
Zhang, M. et al. (2018). The association between the NAT2 genetic polymorphisms and risk of DILI during anti‐TB treatment: a systematic review and meta‐analysis. British journal of clinical pharmacology. pp. 2747-2760. [Online].